Are you a robotics manufacturer?
Claim your page to correct your specs and keep your listing current.
Bioservo is a robotics company founded 2014, based in Sweden, developing 1 robot primarily in the Exoskeleton category.
CAPITAL & EVIDENCE
Shipped
No deployment evidence on file
A deployment is recorded when a public source names both the customer and the robot, or the maker confirms it. Nothing here counts against Bioservo.
In Exoskeleton, exoIQ, ExoAtlet and Hyundai Motor Group have deployment evidence on file.
Add a deployment →World's first active soft exoskeletons for the hand, empowering users with impaired hand function to regain independence and quality of life.
Bioservo Technologies AB develops active soft exoskeletons for the hand, including the Carbonhand and Ironhand systems. These assistive medical devices enhance grip strength, hand function, and independence for individuals with conditions such as spinal cord injury, ALS, MS, stroke, and orthopedic injuries. Carbonhand uses pressure sensors to detect user-initiated grip and applies power for a firm hold, while Ironhand offers similar functionality with adjustable resistance. Products are prescribed and reimbursed through national healthcare systems, primarily in Sweden and the US, targeting patients, caregivers, and rehabilitation centers.
Active products
1
RoboIndex
45.25
RoboScore 45.25 + Momentum 0.00
Company facts
- HQ
- Kista, Sweden
- Founded
- 2014 · 12 yrs
- Employees
- 51
- Website
- www.bioservo.com
RoboScore
45.25 RoboScore + 0.00 Momentum· Adequate evidence
Products 65%, Depth 5%, Evidence 30% set the number, and every rated company has all three. Attention has no weight of its own — it is one of the two things Evidence is built from, and it can only ever add. Activity and Readiness describe the brand but never move it. A value we don't have reads —, never zero. Momentum is independently collected news coverage, worth at most 15 points and never a deduction — a maker we have heard nothing about keeps its full RoboScore. Claiming or paying moves nothing.
4 of 6 factors known. How it's calculated
Milestones
Bioservo collaborates with Limb Lab to expand Carbonhand accessibility across the United States.
Clinical trials with 367 participants demonstrate significant improvements in grip strength, hand function, and quality of life after 4–12 weeks of Carbonhand use.
Carbonhand receives CE marking as an assistive medical device for individuals with impaired hand function.
Press coverage
- Bioservo Collaborates with Limb Lab to Expand Accessibility of Carbonhand Across the United States
Bioservo Press Releases · Mar 2024
- Clinical Evidence Demonstrates Significant Improvements in Grip Strength and Hand Function After Carbonhand Use
Bioservo Clinical Evidence · Jun 2023
Public loss record
Consumer product alerts from this country reach the EU Safety Gate, which we read. Industrial, workplace and medical incidents never enter it, so a blank record says nothing about those.
Active products by Bioservo
1 shown| # | Category | ||||
|---|---|---|---|---|---|
| 1 |  | Carbonhand | Exoskeleton | 2024 | 51.1 |
Exoskeleton buying guides
Industry Knowledge →
The exoskeleton vendor RFP: questions and red flags
Most exoskeleton RFPs focus on spec sheets. The questions that protect you are about fit programs, hygiene, evidence, regulatory clearance, and what happens whe…
A 90-day deployment playbook for industrial exoskeleton programs
A 90-day structured deployment — with ergonomics baseline, task selection, worker fit, hygiene protocol, and measurement — is what separates programs that scale…
Exoskeleton decision framework: passive vs. powered, industrial vs. medical
The exoskeleton market spans four device architectures, two primary buyer types, and dozens of body-region configurations. This framework maps the decision tree…